Department of Biomedical Informatics

COVID-associated delays for elective services studied

This spring in the U.S., there were widespread delays in elective health care procedures and screenings. Hospitals, in observance of federal guidelines, were, for a time, conserving beds and protective equipment in preparation for a surge in COVID-19 admissions. And, perhaps on a more prolonged basis, patients in many areas of the country stayed away due to anxiety over catching COVID-19 from other patients or their health care team.

Model students: improving clinical decision-making

Vanderbilt investigators have devised a system to alert health IT teams to deteriorating performance in clinical prediction models.

Team tracks sources of false positives in urine drug screens

False positives on urine drug screens are common and are frequently due to cross-reactivity of these tests to medications. Last year, Vanderbilt University Medical Center researchers Jacob Hughey, PhD, assistant professor of Biomedical Informatics, and Jennifer Colby, PhD, at that time assistant professor of Pathology, Microbiology and Immunology, devised, tested and published a method to systematically identify medications that interfere with screenings for drugs of abuse.

The End of Life Care Plan is easily accessible on My Health at Vanderbilt.

My Health at Vanderbilt adds End of Life Care Plan

Improvements to the web-based My Health at Vanderbilt, Vanderbilt Health’s online patient portal, have made it easier for health care teams — including patients and their designated health agents — to add and access an End of Life Care Plan to guide medical decision making.

Peterson tapped to direct VUMC’s Center for Precision Medicine

Screening younger women for hereditary cancers may be cost effective

Population-wide screening for genetic variants linked to hereditary breast and ovarian cancer may be cost effective in women between the ages of 20 and 35, according to a study published in JAMA Network Open.

1 10 11 12 13 14 24